To explore the possibility that systemic PTEN reduction might improve survival in SMA, we developed self-complementary adeno-associated virus serotype 9 expressing RNA interference against PTEN (scAAV9-siPTEN; see Materials and Methods). Here, PTEN is linked to proximal spinal muscular atrophy.